Abstract:Abstract Background Estrogen is a hormone that is frequently essential in breast cancer to drive key transcriptional programs by interacting with the estrogen receptor alpha that upregulates proliferative and oncogenic genes and represses apoptotic and tumor suppressor genes. Protein-coding targets of estrogen regulation in breast cancer are well-defined. However, long non-coding RNA (lncRNA) genes account for the majority of human gene catalogs. The coding status of these genes – their accidental, or regulated, translation by ribosomes, under the influence of estrogen – remains a controversial topic. Methods Here, we performed comprehensive transcriptome analysis using RNA-Seq, as well as ribosome profiling using Ribo-Seq, on the same samples: biological replicates of human estrogen receptor alpha (ERa) positive MCF7 breast cancer cells before and after estrogen treatment. We correlated these two datasets, globally highlighting protein-coding and lncRNA differentially expressed genes and transcripts that were positively as well as negatively responsive to estrogen, separately at the transcriptional level and the translational (as approximated by ribosome binding) level. Results Our data showed that some transcripts were more robustly detected in RNA-Seq than in the ribosome-profiling data, and vice versa, suggesting distinct gene-specific estrogen responses at the transcriptional and the translational level, respectively. Certain differentially expressed transcripts may point to the regulation of alternative splicing by estrogen. Several pseudogenes were co- and anti-regulated with their cancer-functional parental genes. Gene ontology analysis highlighted cancer-relevant pathways enriched after estrogen treatment in cells. Conclusions Our study represents a significant advance in the estrogen receptor biology, because we demonstrated global effects of estrogen on splicing and translation that are distinct from, and not always correlated with, its effects on transcription, and that differ globally for protein-coding and lncRNA genes. We have also highlighted for the first time the transcriptional and translational response of expressed pseudogenes to estrogen, pointing to new perspectives for biomarker and drug-target development for breast cancer in future.

Mechanisms for estrogen receptor expression in human cancer

[Molecular Mechanisms of Regulation of Estrogen Receptor a Expression Level in Breast Cancer].

Epigenomics-based Identification of Oestrogen-Regulated Long Noncoding RNAs in ER+ Breast Cancer.

Estrogen and Its Receptors in Cancer

Estrogen and Cancer

Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors

Role of estrogen receptor in breast cancer cell gene expression.

Estrogen Biosynthesis and Signal Transduction in Ovarian Disease

The Role of Estrogen Receptor Beta in Breast Cancer.

Role of estrogen receptors in health and disease

Therapeutic Value of Estrogen Receptor α in Hepatocellular Carcinoma Based on Molecular Mechanisms

Effects Of Estrogen On Breast Cancer Development: Role Of Estrogen Receptor Independent Mechanisms

Estrogen Receptor Function: Impact on the Human Endometrium

Aromatase Expression and Regulation in Breast and Endometrial Cancer.

Progress on Estrogen Receptor and Female Reproduction

Estrogen-Receptor Expression and Function in Female Reproductive Disease

Estrogen receptors and extracellular matrix: the critical interplay in cancer development and progression

Integration of RNA-seq and Ribosome Profiling to Characterize Transcriptional and Translational Estrogen Responses of Genes in Human Breast Cancer

ER is an RNA-binding protein sustaining tumor cell survival and drug resistance

Molecular mechanism of estrogen–estrogen receptor signaling